Biotechnology News

Completes clinical trial-scale production of cGMP Cepharanthine-2HCL drug substanceOptimized manufacturing processes substantially increases drug product yield To initiate ICH-compliant stability, forced degradation and drug product manufacturing in support of IND filing and clinical requirementsToronto, Ontario--(Newsfile Corp
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2022-10-04 7:00 AM EDT | PharmaDrug Inc.

Toronto, Ontario--(Newsfile Corp. - October 3, 2022) - ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to announce that further to the news release on September 15, 2022, the Company's wholly-owned subsidiary, Naturevan Nutrition Ltd. ("Naturevan"), will further expand distribution of its products to Japan...
Technology, Biotechnology
2022-10-03 8:00 AM EDT | ScreenPro Security Inc.

VINIA® sales orders reached a record high of USD 1.71M representing 145% growth compared to Q3 2021 and 81% growth compared to Q2 2022Q3 Sales in the US delivered 3X the sales of Q2 2022 and crossed the USD 1 Million mark Strong sales momentum and increase in subscribers support...
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Cultivator
2022-10-03 7:30 AM EDT | BioHarvest Sciences Inc.

Oakville, Ontario--(Newsfile Corp. - October 3, 2022) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of cardiovascular diseases ("CVD"), announced today that study results demonstrate the...
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2022-10-03 7:27 AM EDT | Cardiol Therapeutics Inc.

San Diego, California--(Newsfile Corp. - September 30, 2022) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing proprietary, synthetic cannabinoid derivatives to treat glaucoma and other diseases with significant unmet needs, reports that its stockholders voted in favor of all proposals presented at its special...
Biotechnology, Pharmaceuticals, Cannabis, Health
2022-09-30 3:24 PM EDT | Skye Bioscience, Inc.

Toronto, Ontario--(Newsfile Corp. - September 30, 2022) -  Bloom Burton & Co. ("Bloom Burton") is pleased to announce Pieter Cullis, Co-Founder of Acuitas Therapeutics, as the recipient of the 2022 Bloom Burton Award. Pieter Cullis led the development of lipid nanoparticle (LNP) delivery systems for molecular therapeutics at Acuitas Therapeutics....
Technology, Biotechnology, Investment Banking, Health
2022-09-30 7:27 AM EDT | Bloom Burton & Co. Inc.

Vancouver, British Columbia--(Newsfile Corp. - September 29, 2022) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders is pleased to announce that the company has produced 1.5...
Technology, Biotechnology, Health
2022-09-29 8:30 AM EDT | Nova Mentis Life Science Corp.

All resolutions submitted for approval were passed by shareholdersVancouver, British Columbia--(Newsfile Corp. - September 29, 2022) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF), a clinical stage biotech company dedicated to developing a first-in-class neuroreparative drug to treat nervous system damage, announces the results of its Annual General Meeting of...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2022-09-29 8:30 AM EDT | NervGen Pharma Corp.

Vancouver, British Columbia--(Newsfile Corp. - September 29, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceuticals company primarily focussed on the development of novel immune-oncology vaccines and drug delivery technologies including Antibody Drug Conjugate ("ADC"), is pleased to announce that...
Biotechnology, Pharmaceuticals, Health
2022-09-29 3:15 AM EDT | Defence Therapeutics Inc.

Oakville, Ontario--(Newsfile Corp. - September 28, 2022) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of cardiovascular diseases ("CVD"), announced today that an abstract submitted by...
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2022-09-28 8:20 AM EDT | Cardiol Therapeutics Inc.

Toronto, Ontario--(Newsfile Corp. - September 28, 2022) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, is pleased to announce that its board of directors (the "Board") has appointed Philip Lambert, Ph.D.,...
Biotechnology, Pharmaceuticals, Health
2022-09-28 7:30 AM EDT | Satellos Bioscience Inc.

Salt Lake City, Utah--(Newsfile Corp. - September 27, 2022) - Gaensel Energy Group, Inc., (OTC Pink: GEGR) ("Gaensel" or the "Company"), a diversified holding company, announces a corporate update. On August 5 GEGR acquired 50% of a group of Italian magazines owns by Le Roy srl. Group Editorial Le Roy...
Biotechnology, Cannabis, Alternative Energy, Cannabis Cultivator
2022-09-27 11:19 AM EDT | Gaensel Energy Group, Inc.

Calgary, Alberta--(Newsfile Corp. - September 27, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce the appointment of Dr. Ernst von Schwarz, MD, PhD, FESC, FACC, FSCAI to its Scientific Advisory Board.Dr. von Schwarz is a US based world renowned, triple...
Biotechnology, Pharmaceuticals, Health
2022-09-27 9:00 AM EDT | Hemostemix Inc.

Jackson Center, Pennsylvania--(Newsfile Corp. - September 27, 2022) - Halberd Corporation (OTC Pink: HALB) entered into a strategic alliance with AI Longevity, Inc. and Stem of Hope to form a strategic alliance as a wholly owned subsidiary of Halberd Corporation named "ExtendalifeTM". The mission will be to develop treatments intended...
Biotechnology, Pharmaceuticals, Health
2022-09-27 8:00 AM EDT | Halberd Corp.

Calgary, Alberta--(Newsfile Corp. - September 26, 2022) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), today announced that its board of directors has approved the grant of incentive stock options (the "Options") to certain directors and officers to acquire...
Biotechnology
2022-09-26 4:38 PM EDT | Marvel Biosciences Corp.

Toronto, Ontario--(Newsfile Corp. - September 26, 2022) - Zonetail Inc. (TSXV: ZONE) (OTCQB: ZTLLF) ("Zonetail") announces it has signed a groundbreaking agreement with MealMe, Inc. ("MealMe") a leader in embedded commerce technology. Zonetail is partnering with MealMe to allow users of the Zonetail mobile application to purchase over 300,000,000 food,...
Technology, Biotechnology, Leisure/Travel/Hotels
2022-09-26 7:30 AM EDT | Zonetail Inc.

Salt Lake City, Utah--(Newsfile Corp. - September 26, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") announced that its stockholders authorized a reverse stock split of the Company's common stock. Following the annual stockholder meeting, the board of directors approved a reverse stock split of one share...
Biotechnology, Pharmaceuticals
2022-09-26 6:45 AM EDT | Kiora Pharmaceuticals, Inc.

Bill Radvak, Co-founder and Executive Chairman of the Board, appointed interim Chief Executive Officer Dr. Adam Rogers, member of the Board of Directors, appointed interim President Paul Brennan to step down as President & Chief Executive Officer and member of the Board of Directors; will serve as a strategic advisor...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2022-09-22 7:21 PM EDT | NervGen Pharma Corp.

Vancouver, British Columbia--(Newsfile Corp. - September 22, 2022) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest" or the "Company") announces that pursuant to the Company's existing Stock Option Plan, a total of 1,000,000 incentive stock options have been granted to a consultant of the Company. These stock options are exercisable at...
Technology, Biotechnology, Pharmaceuticals, Alternative Energy
2022-09-22 2:51 PM EDT | Solarvest BioEnergy Inc.